VRCA

NASDAQStock

Verrica Pharmaceuticals Inc.

$6.04-0.10 (-1.71%)

52-Week Range

$3.28

$9.10

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.46

Volume

59.4K

Avg Volume

128.0K

Performance

+10.61%

-18.65%

+24.49%

YTD

-25.90%

+14.46%

-90.75%

-96.48%

Price Chart

ETF Exposure

VRCA is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
AVTM	Avantis Total Equity Markets ETF 1	0.00%	481	$3K	$803.1M	0.23%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	2	$24	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	92	$883	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	0	$4	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	52,821	$371K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	277	$3K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	23	$228	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	57,785	$406K	$84.10B	0.05%

About VRCA ETF Exposure

Verrica Pharmaceuticals Inc. (VRCA) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $6.04. Investors can gain exposure to VRCA through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold VRCA, sorted by portfolio weight.